Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
So, i get in tonight and was 5 or so minutes late in joining the webinar, I was sitting here, laptop on my knee, when halfway through, the damn thing overheated (blocked the fan vent with my knee!) and shut down. By the time i registered again to join, i had missed certain parts.
From what i can see on the comments, i think there is a misconception that we are 2 years away from anything. This is not true. What Allan said is that we are fully funded for the program for the next two years - quite a different thing.
As for "not having a product yet", again i think that is incorrect. We already have a test, but we are looking for CE / FDA marking TO COMMERCIALISE it. Also, he did stress the different revenue streams. One being the licensing of our technology. Something that can be done now. In fact i think that this route is already in progress.
Someone mentioned Grail. This is spin out company (sound familiar?) from Illumina.This was one of the companies i was researching last year, as they were due to IPO on the market around the time we were speculating about the possible target, and issued a prospectus for $100millioin. As it turned out, the IPO wAs pulled, and Illumina bought their own company back for the sum of $8 BILLION That' a hell of a re-rate. They clearly saw the value . Now, just think, what if sometime in the future they bought us too, given that we are in the same market.
I said we were going into an exciting target, and i am more than happy with what i see. .
This has the potential to be MASSIVE.
Neil
re - someone mentioned Grail it was Allan Syms himself ! your description of events is about right even tho you had probs ! thanks
Agree -:
This has the potential to be MASSIVE.
They have enough money for now. The earliest time they can do some fund raise it’s in the second half of next year( it’s in prospectus)!!! no one said they will do it of course. We will be in pounds by then! IMO they have something big to announce very shortly. Imagine in the future when they will be approved first time in history for a quick early detection lung cancer tests via blood test!! It’s a no brainer. I have couple ££££ to put on relist day if mm’s will allow me to buy it... I sense many will be surprised of market reaction :-))
I also think "CIZ" could be massive. I doubt that it will be just lung cancer that can be detected early, CIZ could help to early identify a number of be a number of cancers.